BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1629 related articles for article (PubMed ID: 26361680)

  • 21. Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients.
    Taura K; Ikai I; Hatano E; Yasuchika K; Nakajima A; Tada M; Seo S; Machimoto T; Uemoto S
    Surgery; 2007 Nov; 142(5):685-94. PubMed ID: 17981188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.
    Hanouneh IA; Macaron C; Lopez R; Aucejo F; Zein NN
    Transplant Proc; 2011 Dec; 43(10):3813-8. PubMed ID: 22172852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downstaging disease in patients with hepatocellular carcinoma outside of Milan criteria: strategies using drug-eluting bead chemoembolization.
    Green TJ; Rochon PJ; Chang S; Ray CE; Winston H; Ruef R; Kreidler SM; Glueck DH; Shulman BC; Brown AC; Durham J
    J Vasc Interv Radiol; 2013 Nov; 24(11):1613-22. PubMed ID: 24060436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.
    Mazzaferro V; Sposito C; Zhou J; Pinna AD; De Carlis L; Fan J; Cescon M; Di Sandro S; Yi-Feng H; Lauterio A; Bongini M; Cucchetti A
    Gastroenterology; 2018 Jan; 154(1):128-139. PubMed ID: 28989060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Milan criteria versus San Francisco criteria in hepatocellular carcinoma: our center's experience.
    Sánchez Antolín G; García Pajares F; Pérez E; Villacastín E; Ruiz Rebollo L; Sánchez DP; Cítores MA; Velicia Llames R
    Transplant Proc; 2009 Apr; 41(3):1012-3. PubMed ID: 19376413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-Fetoprotein as a Modifier of Anatomic Criteria for Transplantation of HCC Patients.
    Daoud A; Soliman K; Teeter L; Ali H; Graviss EA; Mogawer S; Sholkamy A; El-Shazli M; Gaber AO
    Transplant Proc; 2021 Apr; 53(3):833-838. PubMed ID: 33589231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of hepatocellular carcinoma with liver transplantation: a single-center experience from Brazil.
    Teixeira AC; Mente ED; Castro-e-Silva O; Sankarankutty AK; Cantão CA; Souza FF; Abud D; Muglia V; Elias-Junior J; Martinelli AL
    Transplant Proc; 2010 Mar; 42(2):502-4. PubMed ID: 20304177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of Liver Transplantation in Hepatocellular Carcinoma Patients at Siriraj Hospital.
    Kositamongkol P; Sanphasitvong V; Sirivatanauksorn Y; Pongpaibul A; Limsrichamrern S; Mahawithitwong P; Asavakarn S; Tovikkai C; Dumronggittigule W
    Transplant Proc; 2017 Jun; 49(5):1114-1117. PubMed ID: 28583538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of resection and transplantation for hepatocellular carcinoma in cirrhosis and noncirrhosis.
    Rayya F; Harms J; Bartels M; Uhlmann D; Hauss J; Fangmann J
    Transplant Proc; 2008 May; 40(4):933-5. PubMed ID: 18555082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for hepatitis B virus-related hepatocellular carcinoma: one center's experience in China.
    Xiao L; Fu ZR; Ding GS; Fu H; Ni ZJ; Wang ZX; Shi XM; Guo WY
    Transplant Proc; 2009 Jun; 41(5):1717-21. PubMed ID: 19545714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience.
    Bonadio I; Colle I; Geerts A; Smeets P; Berardi G; Praet M; Rogiers X; de Hemptinne B; Van Vlierberghe H; Troisi RI
    Clin Transplant; 2015 May; 29(5):425-33. PubMed ID: 25808782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transplantation for Hepatocellular Carcinoma: Is There a Tumor Size Limit?
    Daoud A; Teeter L; Ghobrial RM; Graviss EA; Mogawer S; Sholkamy A; El-Shazli M; Gaber AO
    Transplant Proc; 2018 Dec; 50(10):3577-3581. PubMed ID: 30577241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma.
    Piardi T; Gheza F; Ellero B; Woehl-Jaegle ML; Ntourakis D; Cantu M; Marzano E; Audet M; Wolf P; Pessaux P
    Ann Surg Oncol; 2012 Jun; 19(6):2020-6. PubMed ID: 22179632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sirolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma.
    Zimmerman MA; Trotter JF; Wachs M; Bak T; Campsen J; Skibba A; Kam I
    Liver Transpl; 2008 May; 14(5):633-8. PubMed ID: 18324656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.
    Choi HJ; Kim DG; Na GH; Han JH; Hong TH; You YK
    World J Gastroenterol; 2013 Aug; 19(29):4737-44. PubMed ID: 23922471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond Milan criteria--chances and risks of expanding transplantation criteria for HCC patients with liver cirrhosis.
    Koschny R; Schmidt J; Ganten TM
    Clin Transplant; 2009 Dec; 23 Suppl 21():49-60. PubMed ID: 19930317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation for hepatocellular carcinoma: results of a multicenter study with common priorization criteria.
    Santoyo J; Sanchez B; de la Mata M; Fernández-Aguilar JL; Lopez-Ciller P; Pascasio JM; Suarez MA; Gomez MA; Nogueras F; Muffak K; Cuende N; Alonso M
    Transplant Proc; 2009 Apr; 41(3):1009-11. PubMed ID: 19376412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
    Lee KW; Yi NJ; Suh KS
    Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
    Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
    Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
    Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
    Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 82.